These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102. Perceptions of Canadian vascular surgeons toward pharmacological risk reduction in patients with peripheral arterial disease. Al-Omran M; Lindsay TF; Major J; Jawas A; Leiter LA; Verma S; Ann Vasc Surg; 2006 Sep; 20(5):555-63. PubMed ID: 16871436 [TBL] [Abstract][Full Text] [Related]
103. Variation in initiating secondary prevention after myocardial infarction by hospitals and physicians, 1997 through 2004. Margulis AV; Choudhry NK; Dormuth CR; Schneeweiss S Pharmacoepidemiol Drug Saf; 2011 Oct; 20(10):1088-97. PubMed ID: 21538672 [TBL] [Abstract][Full Text] [Related]
104. [Medical management of patients with stable coronary artery disease in France in 2004. Data from the Mutualité Sociale Agricole]. Jeantet M; Gosselin S; Lefrand E; Hunold H; Vanbockstael V; Bertrand D; Danchin N Presse Med; 2006; 35(7-8):1123-30. PubMed ID: 16840887 [TBL] [Abstract][Full Text] [Related]
105. Antithrombotic management after an ischemic stroke in French primary care practice: results from three pooled cross-sectional studies. Touzé E; Cambou JP; Ferrières J; Vahanian A; Coppé G; Leizorovicz A; Jullien G; Guérillot M; Herrmann MA; Mas JL Cerebrovasc Dis; 2005; 20(2):78-84. PubMed ID: 15976499 [TBL] [Abstract][Full Text] [Related]
106. Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome. Cottin Y; Cambou JP; Casillas JM; Ferrières J; Cantet C; Danchin N J Cardiopulm Rehabil; 2004; 24(1):38-44. PubMed ID: 14758102 [TBL] [Abstract][Full Text] [Related]
107. [Utilization of the principle therapeutic classes for cardiovascular prevention in elderly patients seen by cardiologists. The ELIAGE survey]. Philippe F; Danchin N; Quentzel S; Cambou JP Ann Cardiol Angeiol (Paris); 2004 Nov; 53(6):339-46. PubMed ID: 15603177 [TBL] [Abstract][Full Text] [Related]
108. [Antithrombotic drugs in the prevention of ischemic stroke]. Bousser MG J Mal Vasc; 2005 Dec; 30(5):267-79. PubMed ID: 16439939 [TBL] [Abstract][Full Text] [Related]
109. Use of secondary prevention pharmacotherapy after first myocardial infarction in patients with diabetes mellitus. Jørgensen CH; Gislason GH; Ahlehoff O; Andersson C; Torp-Pedersen C; Hansen PR BMC Cardiovasc Disord; 2014 Jan; 14():4. PubMed ID: 24406095 [TBL] [Abstract][Full Text] [Related]
110. Missed opportunities for the secondary prevention of cardiovascular disease in Canada. Hackam DG; Leiter LA; Yan AT; Yan RT; Mendelsohn A; Tan M; Zavodni L; Chen R; Tsang JL; Kundi A; Lin PJ; Fitchett DH; Langer A; Goodman SG; Can J Cardiol; 2007 Dec; 23(14):1124-30. PubMed ID: 18060097 [TBL] [Abstract][Full Text] [Related]
111. Changing patterns of medical treatment in acute myocardial infarction. Observations from the Perth MONICA Project 1984-1990. Thompson PL; Parsons RW; Jamrozik K; Hockey RL; Hobbs MS; Broadhurst RJ Med J Aust; 1992 Jul; 157(2):87-92. PubMed ID: 1352848 [TBL] [Abstract][Full Text] [Related]
112. Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study. Ramsay SE; Whincup PH; Wannamethee SG; Papacosta O; Lennon L; Thomas MC; Morris RW J Public Health (Oxf); 2007 Sep; 29(3):251-7. PubMed ID: 17584949 [TBL] [Abstract][Full Text] [Related]
113. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Hira RS; Cowart JB; Akeroyd JM; Ramsey DJ; Pokharel Y; Nambi V; Jneid H; Deswal A; Denktas A; Taylor A; Nasir K; Ballantyne CM; Petersen LA; Virani SS Am J Cardiol; 2016 Oct; 118(8):1144-1149. PubMed ID: 27553104 [TBL] [Abstract][Full Text] [Related]
114. Secondary prevention of coronary heart disease in older patients after the national service framework: population based study. Ramsay SE; Whincup PH; Lawlor DA; Papacosta O; Lennon LT; Thomas MC; Ebrahim S; Morris RW BMJ; 2006 Jan; 332(7534):144-5. PubMed ID: 16401630 [TBL] [Abstract][Full Text] [Related]
115. Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study. Gallo A; Galliazzo S; Grazioli S; Guasti L; Ageno W; Squizzato A J Thromb Thrombolysis; 2019 Aug; 48(2):336-344. PubMed ID: 31177486 [TBL] [Abstract][Full Text] [Related]
116. Relationship Between Provider Experience and Cardiac Performance Measures in Outpatients (from the NCDR). Carney K; Thande N; Gosch K; Desai N Am J Cardiol; 2020 Mar; 125(5):820-826. PubMed ID: 31898968 [TBL] [Abstract][Full Text] [Related]
117. [Role of cardiologists in control of risk factors and prescription of secondary-preventive drugs in elderly patients with atherosclerotic cardiovascular disease. The French ELIAGE-MG survey]. Danchin N; Amelineau E; Quentzel S; Cambou JP Ann Cardiol Angeiol (Paris); 2006 Jan; 55(1):17-21. PubMed ID: 16457031 [TBL] [Abstract][Full Text] [Related]